Search tips
Search criteria 


Logo of plospathPLoS PathogensSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)View this Article
PLoS Pathog. 2010 April; 6(4): e1000886.
Published online 2010 April 29. doi:  10.1371/journal.ppat.1000886
PMCID: PMC2861711

Candida albicans Interactions with Bacteria in the Context of Human Health and Disease

Hiten D. Madhani, Editor

Humans are colonized by diverse populations of bacteria and fungi when in a healthy state and in the settings of disease, and the interactions between these microbial populations can be beneficial or detrimental to the host [1]. Among these microbial populations, Candida albicans is the fungus most commonly detected in association with humans [2], and numerous studies have described C. albicans interactions with its bacterial neighbors [1]. Here, with a focus on C. albicans, we provide examples of how bacterial-fungal interactions can influence human health. In addition, we highlight studies that give insight into the molecular mechanisms that govern the physical associations, interspecies communication, and changes in microbial behavior and survival that occur when bacteria and fungi occupy the same sites.

Bacterial−C. albicans Interactions Can Promote or Prevent Disease

Bacterial and fungal co-infections have been implicated in enhanced host colonization and virulence. For instance, C. albicans and Escherichia coli exhibit a cooperative interaction wherein E. coli enhances adhesion of C. albicans to bladder mucosa and increases the likelihood of fungal urinary tract infections [3]. Likewise, the risk of ventilator-associated pneumonia due to infection by Pseudomonas aeruginosa is markedly greater in patients colonized by C. albicans [4], and accordingly, antifungal treatments can reduce the likelihood of developing this systemic disease [5]. Moreover, denture stomatitis, an inflammation of the oral mucosa in denture wearers, is influenced by the presence of C. albicans and other oral microorganisms [6]. In fact, several studies demonstrate an association between C. albicans and oral bacteria such as Streptococcus (Figure 1A), Actinomyces, and Fusobacterium species [1], [7], and these physical interactions likely contribute to denture colonization and oral candidiasis.

Figure 1
An overview of how interactions between C. albicans and Gram-positive members of the human flora may influence disease.

In contrast, lactic acid bacteria (Figure 1B), which normally inhabit the intestinal and female reproductive tracts, compete with C. albicans for adhesion sites and secrete substances that inhibit fungal attachment to control C. albicans invasion and disease [8]. Interestingly, imbalance in the normal bacterial flora caused by treatment with broad-spectrum antibiotics is a predisposing factor associated with C. albicans colonization of immunocompromised patients, probably due to decreased numbers of bacterial competitors [9]. Thus, antibiotic therapies that specifically target pathogens, in contrast to broad spectrum antibiotics, may help prevent secondary problems that arise upon perturbation of beneficial bacterial-fungal interactions.

Bacteria and Fungi Promote Coaggregation and Formation of Mixed-Species Biofilms

Both singly and together, bacteria and fungi form highly structured, often surface-associated, communities termed biofilms. A significant proportion of human microbial infections are biofilm-associated, wherein the formation of mixed-species biofilms could create a protected environment that allows for survival to external assaults and facilitates different bacterial-fungal interactions [1], [2]. The known relationships between C. albicans and oral streptococci illustrate the various ways by which bacteria and fungi can attach to one another or coaggregate using specific cell surface factors, leading to mixed-species biofilms [2], [7]. These adhesive interactions between C. albicans and other indigenous oral microbes can be mediated by protein-protein and lectin-carbohydrate interactions, and hydrophobic and electrostatic interactions may contribute as well. C. albicans molecules such as agglutinin-like sequences (Als) and specific cell surface glycoproteins have been identified as being important for coadhesion to mixed microbial communities in biofilms [1], [10]. O'Sullivan and colleagues [11] demonstrated that the oral bacterium Streptococcus gordonii adsorbs salivary proline-rich proteins that are recognized by C. albicans and act as receptors for the fungus (Figure 1A). Importantly, S. gordonii cell surface polypeptides also contribute to coadherance with the fungi [12]. Underscoring the complexity of these interactions, adherence and coaggregation of C. albicans with oral bacteria is species specific, and is mediated by bacterial receptors that might be expressed only under particular environments.

Interdomain Signaling via Quorum-Sensing Molecules and Other Microbial Products Modulates Fungal and Bacterial Behavior

Single species bacterial and fungal populations modulate their collective behavior using extracellular signals known as quorum-sensing molecules [13], [14]. Since this regulation generally occurs in response to cell density, processes like co-aggregation and biofilm formation promote the synthesis and secretion of quorum-sensing molecules, increasing the likelihood that neighboring cells will experience the signals at levels sufficient to induce a response. Thus, the study of bacterial-fungal interactions in association with mixed-species biofilms reveals that cross-kingdom communication between bacteria and fungi is a common process, and that quorum-sensing signals, known for their roles in intraspecies communication, can also mediate crosstalk between bacteria and fungi. C. albicans, as an illustration, induces its switch from hyphal growth to yeast growth using a secreted quorum-sensing molecule called farnesol [14], which inhibits the Ras1-controlled pathway involved in hyphal growth [15]. Strikingly, this small molecule can also modulate bacterial behavior and virulence by altering the production of toxic phenazines, such as pyocyanin in P. aeruginosa [13]. Moreover, farnesol can also induce the generation of reactive oxygen species in a number of microorganisms, likely through effects on electron transport chain components [16], and this process may play an important role in competition with bacteria.

Notably, a number of Gram-negative bacteria secrete molecules with farnesol-like activities in that they induce a shift to yeast form growth by the fungus [17]. For instance, P. aeruginosa–produced 3-oxo-C12-homoserine lactone reaches concentrations in mixed-species biofilms that repress C. albicans filamentation [17]. By responding to these signaling molecules, the fungus may disperse from sites where other co-inhabitants such as antifungal-producing bacteria are present, conferring a potential selective advantage. Conversely, in mixed biofilms of S. gordonii and C. albicans (Figure 1A), a bacterially secreted diffusible signal enhances hyphal development by relieving the effects of farnesol on the fungus [7]. Moreover, cell wall–derived molecules such as bacterial muramyl dipeptides induce C. albicans hyphal growth, which may also promote fungal invasion of host tissues and virulence [18]. These findings support the concept that both eukaryotic and prokaryotic microorganisms sense and respond to the diverse diffusible signaling molecules produced in the niches where they coexist. Furthermore, we may find that the chemical warfare between bacteria and fungi leads to increased toxin production and increased host damage and inflammation.

Chemical Interactions between Fungi and Bacteria

In addition to providing attachment sites for different species, bacterial-fungal communities create environmental conditions that promote or control the growth of other microbes. Actively respiring C. albicans reduces oxygen tension levels and provides stimulatory factors for streptococci in the oral environment, while the latter provides nutrients that promote fungal growth [1]. In contrast, commensal bacteria that inhabit the female reproductive tract, such as Lactobacillus spp. (Figure 1B), inhibit the growth and virulence of C. albicans potentially through secretion of organic acids and production of hydrogen peroxide (H2O2). Supporting these in vitro findings, it has been shown that 96% of healthy women have H2O2-generating Lactobacillus species as part of their microflora, while these bacterial populations are lower in women suffering from vaginosis [8].

Bacterial-Fungal Interactions Influence Antibiotic Resistance and Host Response to Infection

Mixed bacterial-fungal infections can correlate with increased frequency or severity of disease. In fact, while C. albicans is the fourth leading cause of mortality due to systemic infections [1], [19], the risk of mortality may increase upon bacterial and fungal co-infection. C. albicans and Staphylococcus aureus, for instance, have synergistic effects where mice inoculated with only S. aureus show low mortality, whereas co-inoculation with C. albicans leads to mortality increases [1], [20]. It is not yet known how the host immune response is perturbed when bacterial and fungal pathogens are both present, but current research seeks to address this important question. The cooperative effects observed in mixed fungal-bacterial infections in vivo could be due to formation of biofilms, since this form of growth can promote resistance to both host clearance pathways and antimicrobial agents. Harriott and Noverr demonstrated that the human pathogen S. aureus forms larger biofilms with increased resistance to vancomycin when it is co-cultured with C. albicans [19]. Biofilms of C. albicans and oral streptococci are similarly more resistant to antibiotics than their single species counterparts [1], [2]. Matrix polymers produced by both organisms might result in a more viscous matrix that is more effective at restricting the penetration of drugs [2], [19]. Understanding the physiology of bacteria and fungi coexisting within mixed microbial communities will greatly aid our ability to effectively treat opportunistic polymicrobial infections and to modulate the behavior of potentially pathogenic bacteria and fungi in beneficial ways.


The authors have declared that no competing interests exist.

The authors received no specific funding for this article.


1. Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett. 2009;299:1–8. [PubMed]
2. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11:30–36. [PubMed]
3. Levison ME, Pitsakis PG. Susceptibility to experimental Candida albicans urinary tract infection in the rat. J Infect Dis. 1987;155:841–846. [PubMed]
4. Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest. 2006;129:110–117. [PubMed]
5. Nseir S, Jozefowicz E, Cavestri B, Sendid B, Di Pompeo C, et al. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med. 2007;33:137–142. [PubMed]
6. Baena-Monroy T, Moreno-Maldonado V, Franco-Martinez F, Aldape-Barrios B, Quindos G, et al. Candida albicans, Staphylococcus aureus and Streptococcus mutans colonization in patients wearing dental prosthesis. Med Oral Patol Oral Cir Bucal. 2005;10(Suppl 1):E27–E39. [PubMed]
7. Bamford CV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM, et al. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun. 2009;77:3696–3704. [PMC free article] [PubMed]
8. Boris S, Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2000;2:543–546. [PubMed]
9. Hogenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis. 1998;27:702–710. [PubMed]
10. Klotz SA, Gaur NK, De Armond R, Sheppard D, Khardori N, et al. Candida albicans Als proteins mediate aggregation with bacteria and yeasts. Med Mycol. 2007;45:363–370. [PubMed]
11. O'Sullivan JM, Jenkinson HF, Cannon RD. Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology. 2000;146(Pt 1):41–48. [PubMed]
12. Holmes AR, McNab R, Jenkinson HF. Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions. Infect Immun. 1996;64:4680–4685. [PMC free article] [PubMed]
13. Cugini C, Calfee MW, Farrow JM, 3rd, Morales DK, Pesci EC, et al. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol Microbiol. 2007;65:896–906. [PubMed]
14. Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol. 2001;67:2982–2992. [PMC free article] [PubMed]
15. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol. 2008;67:47–62. [PubMed]
16. Machida K, Tanaka T. Farnesol-induced generation of reactive oxygen species dependent on mitochondrial transmembrane potential hyperpolarization mediated by F(0)F(1)-ATPase in yeast. FEBS Lett. 1999;462:108–112. [PubMed]
17. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol. 2004;54:1212–1223. [PubMed]
18. Xu XL, Lee RT, Fang HM, Wang YM, Li R, et al. Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe. 2008;4:28–39. [PubMed]
19. Harriott MM, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother. 2009;53:3914–3922. [PMC free article] [PubMed]
20. Carlson E. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect Immun. 1983;42:285–292. [PMC free article] [PubMed]

Articles from PLoS Pathogens are provided here courtesy of Public Library of Science